No. 1 Market Leader in Concentrated Chinese Medicine Granules (CCMG) in Hong Kong* *In terms of prescription revenue in 2022, according to Euromonitor Report Traditionally, the preparation and dispensation of Traditional Chinese Medicine (TCM) is time-consuming and inconvenient and requires the storage of raw herbs by the Chinese medicine practitioner and the boiling or decocting of …

Adjunct Therapy for Patients with Serious Illness The FIRST Chinese Medicinal Ingredient Verified by the U.S. Pharmacopeia (USP)* New Generation of Yunzhi with Promising Efficacy  – Scientific Innovation Leading to Advancement Oncozac® is a new generation Yunzhi-derived adjunct remedy with enhanced efficacy^ developed for those combating serious illnesses. Developed through rigorous pharmaceutical research conducted in …